Home

Part of our AI Trading ecosystem

AI Trading Tool

The main AI trading tool page

AI Stock Analysis

4,600+ stocks analyzed

AI Stock Picks

Daily AI-generated picks

AI Stock Picker

Scan the universe for ideas

Stock Recommendations

Ranked AI research ideas

AI Trading Signals

Real-time momentum alerts

AI Stock Screener

Scan 4,600+ stocks live

Best AI Trading Tools

#1 pick: Stockinhood

How AI Trading Works

The technology explained

AI Stock Predictions

Multi-timeframe targets

NXATW

Neutral

NextArray Inc. Warrants

Information Technology·Software & Infrastructure

$0.08

Current Price

$4.5M

Market Cap

—

P/E Ratio

$0.25

52W High

$0.03

52W Low

Company Profile

CEO

Executive Leadership

Employees

45

Year Founded

2019

Headquarters

Dallas, Texas, United States

Sector / Industry

Information Technology · Software & Infrastructure

Key Statistics

Market Cap

$4.5M

Today's High

$0.09

Today's Low

$0.08

Open

$0.08

Previous Close

$0.08

52-Week High

$0.25

52-Week Low

$0.03

Today's Volume

12.8K

Avg. Volume

25.4K

Overnight Volume

1.2K

Shares Outstanding

15.2M

P/E Ratio

0.00

EPS

$-0.12

Beta

1.95

Dividend Yield

0.00%

Live market stats are a premium feature

These stats are from a cached snapshot. Unlock real-time data with lifetime access — $19.99.

Earnings History

Quarterly expected vs. actual performance

Q2 20262026-08-14
Beat 33%
EPS Est.-0.03
EPS Actual-0.02
Rev. Est.$1.4M
Rev. Actual$1.5M
Q1 20262026-05-15
Beat 0%
EPS Est.-0.04
EPS Actual-0.04
Rev. Est.$1.2M
Rev. Actual$1.25M
Q4 20252026-03-27
Missed -20%
EPS Est.-0.05
EPS Actual-0.06
Rev. Est.$1.1M
Rev. Actual$1.05M
Q3 20252025-11-14
Missed -25%
EPS Est.-0.04
EPS Actual-0.05
Rev. Est.$950K
Rev. Actual$910K

Earnings data is AI-compiled from public sources and may be delayed or approximate. Not financial advice.

Historical Price Chart

Price History

Chart data unavailable

AI Price Targets

NXATW represents publicly traded warrants associated with NextArray Inc. Operating as a micro-cap speculative derivative instrument, trading volume remains thin with substantial bid-ask spreads. Directional performance is highly tied to underlying common equity sentiment, structural liquidity, and warrant expiration timelines.

7-Day Target

$0.09

+12.5%

30-Day Target

$0.12

+50.0%

6-Month Target

$0.15

+87.5%

AI Confidence

42%

Risk Level

High

Analyst Target

$0.5

Bull Case

The bull case rests on the potential for FDA clearance of its Generation 2 device to trigger rapid commercial adoption and licensing opportunities. Successful clinical trials showing superior efficacy in treating chronic mental health conditions could position the company as a leader in non-invasive neuromodulation.

Bear Case

The bear case centers on the company's limited revenue history, recurring cash burn, and the potential for regulatory setbacks in clinical trials. High competition from established pharmacological and invasive device incumbents, combined with potential dilution from future capital raises, poses a significant threat to shareholders.

Key Catalysts

  • FDA clearance for the Generation 2 neurostimulation device
  • Positive outcomes from ongoing clinical trials for major depressive disorder
  • Expansion of strategic partnerships and distribution networks
  • Presentation of peer-reviewed data at major psychiatric conferences

Key Risks

  • •Continued history of operating losses and negative cash flow
  • •Dependency on regulatory approvals for product commercialization
  • •Dilution risk due to future equity offerings
  • •Intense competition from established mental health treatment providers
  • •Small-cap volatility and low trading liquidity

Company Overview

Nexalin Technology, Inc. is a medical device company focused on developing non-invasive neurostimulation therapies for mental health disorders. The company's proprietary technology aims to treat conditions like anxiety and depression by targeting deep brain structures without invasive surgical procedures.

Take this research further — free

Open NXATW in the full AI tools and run your own analysis: live charts, 7-day to 6-month targets, and risk checks. 15 minutes free, no card required.

Rather have it all, permanently?

30-day money-back guarantee • Secure payment by Square

NXATW Stock FAQ

What is the AI analysis for NXATW stock?

Stockinhood's AI generates multi-timeframe price targets for NXATW (NextArray Inc. Warrants), including 7-day, 30-day, and 6-month outlooks based on market data, technical indicators, and news sentiment. These estimates are for informational purposes only and do not constitute financial advice.

Is NXATW stock a good investment?

Our AI assigns a sentiment signal (Bullish, Bearish, or Neutral) to NXATW based on multiple factors including price trends, momentum, and market conditions. The current AI signal is Neutral. This is AI-generated research, not financial advice — always consult a licensed advisor before investing.

What is the price target for NXATW?

The AI-generated price target for NXATW is based on multi-timeframe analysis and represents a hypothetical scenario, not a guarantee. The current price is $0.08. Price targets are educational estimates and should not be relied upon for investment decisions.

What are the risks of investing in NXATW?

Continued history of operating losses and negative cash flow Dependency on regulatory approvals for product commercialization Dilution risk due to future equity offerings Intense competition from established mental health treatment providers Small-cap volatility and low trading liquidity All risk analysis is informational only and not financial advice.

What sector is NXATW in?

NextArray Inc. Warrants (NXATW) operates in the Information Technology sector, specifically the Software & Infrastructure industry. This classification helps investors understand the company's business focus and compare it with peers in the same sector.